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use#LAABisphenol A (BPA) is used to manufacture
polymeric materials used for a variety of con-
sumer products. These polymers include epoxy
resins that are used to line food cans (Kang
et al. 2003), polyester-styrene (Factor 1996),
and polycarbonate plastics used for baby bottles
and other containers (Brede et al. 2003). These
polymeric resins and plastics may also be used
in some dental sealants (Sasaki et al. 2005) and
ﬁllings (Joskow et al. 2006), adhesives, protec-
tive coatings, ﬂame retardants (Samuelsen et al.
2001), and water-storage tanks and supply
pipes (Bae et al. 2002). BPA is polymerized
but degrades into its monomeric form over
time, which can be accelerated by heat expo-
sure (Robeson 1985). The monomeric form
can leach from its source into adjacent materi-
als, such as into water or food products.
Several studies have demonstrated detectable
BPA levels in packaged foods that were con-
tained in wrapping or cans coated with BPA
(Lopez-Cervantes and Paseiro-Losada 2003).
Most human exposure is believed to be via
ingestion (Kang et al. 2006).
Recent data have shown widespread expo-
sure to BPA among the U.S. population. In
2,517 participants ≥ 6 years of age in the
2003–2004 National Health and Nutrition
Examination Survey (NHANES III), > 92%
of urine samples had detectable concentrations
of BPA (Calafat et al. 2008). Other researchers
have also measured detectable concentrations
of BPA in a variety of human body ﬂuids and
some tissues. Of potential concern to repro-
ductive and developmental health end points is
the presence of BPA in follicular fluid and
amniotic ﬂuid (Ikezuki et al. 2002), umbilical
cord blood (Schonfelder et al. 2002), and
breast milk (Sun et al. 2004). In studies pub-
lished as early as 1936 (Dodds and Lawson
1936), BPA has been shown to have estrogenic
properties. These findings have been con-
firmed in several subsequent studies (Hong
et al. 2006; Singleton et al. 2006). Human
data on the potential health effects of BPA
exposure are limited.
Adult humans metabolize BPA via hepatic
glucuronidation and sulfation. The biologic
half-life of BPA is approximately 6 hr, with
nearly complete urinary excretion in 24 hr
(Volkel et al. 2002). Therefore, urinary BPA
concentrations primarily reﬂect exposures that
occurred within the last few days preceding the
collection of the urine specimen. However,
because health end points of interest are likely
associated with windows of exposure consist-
ing of time intervals longer than a few days,
information about the temporal variability of
urinary concentrations of BPA is needed to
optimize the design of exposure assessment in
epidemiologic studies. Currently, published
data on the temporal variability of urinary
BPA concentrations are limited. Most studies
include only a single urine sample that may or
may not reflect an individual’s long-term
exposure level. Furthermore, characteristics
that may predict concentrations of BPA, such
as sex, age, and body mass index (BMI), have
not been explored in a large sample of adult
subjects.
Temporal variability in exposure to BPA
can result from changes in exposure sources,
such as diet and product use, and from
changes in BPA metabolism. Therefore, an
individual’s BPA exposure depends on a vari-
ety of factors, and it is likely that concentra-
tions of BPA would vary considerably over
short periods, such as days. Although urinary
BPA concentrations accurately measure a per-
son’s exposure at a single point in time, deter-
mining exposure over time intervals of weeks
or months requires multiple measurements.
Therefore, we designed the present study to
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BACKGROUND: Bisphenol A (BPA) is used to manufacture polymeric materials, such as polycarbon-
ate plastics, and is found in a variety of consumer products. Recent data show widespread BPA
exposure among the U.S. population.
OBJECTIVE: Our goal in the present study was to determine the temporal variability and predictors
of BPA exposure.
METHODS: We measured urinary concentrations of BPA among male and female patients from the
Massachusetts General Hospital Fertility Center.
RESULTS: Between 2004 and 2006, 217 urine samples were collected from 82 subjects: 45 women
(145 samples) and 37 men (72 samples). Of these, 24 women and men were partners and con-
tributed 42 pairs of samples collected on the same day. Ten women became pregnant during the
follow-up period. Among the 217 urine samples, the median BPA concentration was 1.20 µg/L,
ranging from below the limit of detection (0.4 µg/L) to 42.6 µg/L. Age, body mass index, and sex
were not signiﬁcant predictors of urinary BPA concentrations. BPA urinary concentrations among
pregnant women were 26% higher (–26%, +115%) than those among the same women when not
pregnant (p > 0.05). The urinary BPA concentrations of the female and male partner on the same
day were correlated (r = 0.36; p = 0.02). The sensitivity of classifying a subject in the highest tertile
using a single urine sample was 0.64.
CONCLUSION: We found a nonsigniﬁcant increase in urinary BPA concentrations in women while
pregnant compared with nonpregnant samples from the same women. Samples collected from part-
ners on the same day were correlated, suggesting shared sources of exposure. Finally, a single urine
sample showed moderate sensitivity for predicting a subject’s tertile categorization.
KEY WORDS: bisphenol A, endocrine disruptors, environment, human, pregnancy. Environ Health
Perspect 116:173–178 (2008). doi:10.1289/ehp.10605 available via http://dx.doi.org/ [Online
6 November 2007]examine the temporal variability in BPA con-
centrations. We also explored the ability of a
single urine sample to predict an individual’s
longer-term exposure, over weeks or months.
Finally, we also investigated the association of
urinary BPA concentrations with age, BMI,
sex, and pregnancy status. In regard to epi-
demiologic studies, this information can be
used for designing exposure assessment strate-
gies and for adjusting for measurement error
in BPA exposure.
Methods
Subjects. Study subjects were male and female
partners seeking infertility evaluation and treat-
ment at the Massachusetts General Hospital
Fertility Center. They were recruited between
November 2004 and April 2006. Partners
underwent ovulation induction with timed
intercourse or timed intrauterine insemination
and assisted reproductive technologies, which
included in vitro fertilization and intra-
cytoplasmic sperm injection. Fertility center
couples that conceived naturally were also
enrolled. Subjects were followed from recruit-
ment throughout their treatment cycles until
either a live birth or the discontinuation of
treatment. Biochemical pregnancy was deter-
mined with a positive  HCG (human chori-
onic gonadotropin) level (> 6.0 IU/L). Clinical
intrauterine pregnancy was conﬁrmed by the
presence of a fetal heartbeat detected by trans-
vaginal ultrasound scan.
The study was approved by the Human
Studies Institutional Review Boards of the
Massachusetts General Hospital, Harvard
School of Public Health, the Centers for
Disease Control and Prevention (CDC), and
the University of Michigan. Subjects signed
an informed consent after the study proce-
dures were explained and all questions were
answered.
Men 18–55 years of age and women
18–45 years of age were eligible. Men who had
undergone a vasectomy were ineligible. Most
study patients cited the lack of time as the pri-
mary reason for not participating. A research
nurse administered a questionnaire to collect
data on date of birth, race/ethnicity, medical
history, smoking history, and lifestyle factors.
Urine sample collection. Both men and
women provided a spot urine sample at the
time of recruitment and at subsequent visits
during treatment cycles, as well as at post-
treatment clinical appointments. Women also
collected three urine samples during preg-
nancy, one during each trimester. Urine was
collected in a nonsterile clean polypropylene
container. After measuring specific gravity
(SG), the urine was divided in aliquots and
frozen at –80°C. Samples were shipped on
dry ice overnight to the CDC.
Urinary BPA measurements. We meas-
ured the total urinary concentration of BPA
(free plus conjugated species) using online
solid-phase extraction (SPE) coupled to isotope
dilution–high-performance liquid chromatog-
raphy (HPLC)-tandem mass spectrometry
(MS/MS) on a system constructed from sev-
eral HPLC Agilent 1100 modules (Agilent
Technologies, Wilmington, DE) coupled to a
triple quadropole API 4000 mass spectrometer
(Applied Biosystems, Foster City, CA) (Ye
et al. 2005). First, 100 µL of urine was treated
with β-glucuronidase/sulfatase (Helix poma-
tia, H1; Sigma Chemical Co., St. Louis, MO)
to hydrolyze the BPA-conjugated species.
BPA was then retained and concentrated on a
C18 reversed-phase size-exclusion SPE col-
umn (Merck KGaA, Germany), separated
from other urine matrix components using a
pair of monolithic HPLC columns (Merck
KGaA), and detected by negative ion-atmos-
pheric pressure chemical ionization-MS/MS.
The limit of detection (LOD) for BPA in a
0.1-mL urine sample was 0.36 µg/L. Low-con-
centration (~ 4 µg/L) and high-concentration
(~ 20 µg/L) quality control materials, prepared
with pooled human urine, were analyzed with
standard, reagent blank, and unknown samples
(Ye et al. 2005). BPA concentrations < LOD
were assigned a value equal to one-half the
LOD (Hornung and Reed 1990) prior to
adjustment by SG.
The first 25 urine samples collected
were analyzed for the concentration of the
free species of BPA using a method similar
to the one described above, but without
β-glucuronidase/sulfatase treatment. In
agreement with published reports (Volkel
et al. 2002), the percentage of free BPA was
essentially zero. Therefore, for the remainder
of the urine samples, we measured only the
total BPA concentration.
Several methods are used to adjust for
urine volume (Boeniger et al. 1993; Teass et al.
1993). However, because organic compounds,
such as phenols, that are glucuronidated in the
liver are eliminated by active tubular secretion
(Boeniger et al. 1993), creatinine adjustment
may not be appropriate (Teass et al. 1993).
Additionally, creatinine concentrations may be
confounded by muscularity, physical activity,
urine ﬂow, time of day, diet, and disease states
(Boeniger et al. 1993; Teass et al. 1993). For
these reasons, we used SG rather than creati-
nine. Urinary BPA concentrations were nor-
malized for dilution using the formula Pc =
P × [(1.024 – 1)/(SG – 1)], where Pc is the
SG-corrected BPA concentration (in micro-
grams per liter), P is the observed BPA concen-
tration (in micrograms per liter), and SG is the
speciﬁc gravity of the urine sample (Boeniger
et al. 1993; Teass et al. 1993). SG was meas-
ured using a handheld refractometer (National
Instrument Company Inc., Baltimore, MD),
which was calibrated with deionized water
before each measurement.
Statistical analysis. Descriptive statistics
and distributions of urinary BPA concentra-
tions were tabulated and compared among
demographic categories. We constructed
graphs to visually and qualitatively compare
BPA concentrations within and between sub-
jects over time. Using SAS software (version
9.1; SAS Institute Inc., Cary, NC), mixed
effects models were ﬁt to determine the asso-
ciation of urinary BPA concentrations (log10)
with age, BMI, sex, and pregnancy status.
Each model included the predictor of interest
and SG as ﬁxed effects. To account for possi-
ble correlation of measurements, random
effects were included initially for subject, cou-
ple, and within-couple specimen collection
date. The variance component for couple was
estimated to be zero and was dropped from
the models, but the random effects for subject
and within-couple collection date were
retained. Full covariate data were available for
all specimens, so information from all samples
was used in the analyses.
To explore the nature of within-couple
correlation, we regressed the geometric mean
of SG-adjusted BPA measurements from the
female partner on that from the male partner.
Another analysis compared BPA measure-
ments (SG-adjusted and log10-transformed)
of the female to those of the male when the
specimens were collected on the same date. In
this model, a random effect was included to
account for a possible correlation due to
repeated measurements from the same couple.
We calculated the sensitivity, specificity,
and positive predictive value of a single urine
sample for predicting high BPA tertile by
comparing predicted and observed classiﬁca-
tions for agreement (Hauser et al. 2004;
Meeker et al. 2005). Positive predictive value
is the probability that a person is actually in
the exposure group of interest, given that they
were classiﬁed in that group based on the sin-
gle urinary BPA value that was available. BPA
tertiles were determined for the SG-adjusted
BPA concentrations among all 82 subjects.
For those with more than one sample, we
used the subject’s geometric mean value in
the tertile classification. A contingency table
was then constructed to display the level of
agreement between each subject’s “true” ter-
tile classification as determined by the geo-
metric mean value of their repeated samples
and their tertile classification predicted by
each of their single repeat samples. Only sub-
jects with three or more urine samples
(31 subjects with a total of 149 urine sam-
ples) were included in the contingency tables.
After combining contingency tables for all
subjects with three or more samples, we cal-
culated sensitivity, specificity, and positive
predictive value for the ability of a given sin-
gle urine sample to classify a subject in the
highest BPA tertile.
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ficity, and positive predictive value of two
urine samples from an individual to classify
subjects in the highest BPA tertile. This analy-
sis was limited to subjects with at least six
repeat urine samples (n = 8 subjects who con-
tributed a total of 67 samples). Geometric
means of all possible combinations of sample
pairings from each individual were used in the
analysis as the predicted value. The geometric
mean value from all possible within-subject
combinations was then compared with the
geometric mean value of their repeated sam-
ples, used to determine their “true” BPA tertile
classification. As above, contingency tables
were then constructed. The goal of the validity
analysis was to simulate and compare the abil-
ity of exposure assessments that involve one or
two urine samples to predict a subject’s “true”
longer-term exposure.
In both of these analyses, the single or two
urine samples used to predict a subject’s tertile
classiﬁcation are not independent predictors of
their overall geometric mean value because
they are also used to calculate the subject’s
geometric mean. For instance, when we calcu-
lated the geometric mean for subjects with
three or more urine samples, the single urine
sample evaluated for its predictive ability was
included in the geometric mean calculation
for that subject. Because of this, we limited
these analyses to subjects with three (or six) or
more urine samples to minimize the structural
dependence between the predicted value based
on the single sample and the “true” observed
values based on the geometric mean of that
subject’s full complement of samples.
Results
Urinary BPA concentrations were measured in
217 samples collected from 82 subjects. On
average, each subject contributed 2.6 urine
samples, ranging from 1 (n = 34 subjects) to
13 samples (n = 1 subject). Twenty-nine
(13%) urine samples had BPA concentrations
< LOD. Forty-five women contributed
145 urine samples and 37 men contributed
72 specimens. Among subjects, 24 women
(93 specimens) and 24 men (53 specimens)
were partners. Of the urine samples from these
24 couples, 42 pairs of specimens were time-
matched (collected on the same day). Eleven
couples had two or more time-matched urine
samples, and 10 couples had a single time-
matched urine sample. Three couples had no
time-matched urine samples.
The study subjects ranged in age from 28
to 54 years, with a mean ± SD of 35.5 ± 4.4
years (Table 1). Seventy subjects (85%) were
Caucasian. Only ﬁve subjects (three men and
two women) were current smokers. BMI (in
kilograms per square meter) ranged from 16.5
to 44.7, with a mean ± SD of 26.8 ± 5.8. Ten
of the women became pregnant during the
follow-up period, as confirmed by the pres-
ence of a fetal heart beat on ultrasound. One
pregnancy loss occurred.
Among the 217 urine samples, the median
BPA concentration was 1.20 µg/L (25th per-
centile, 0.60; 75th percentile, 2.70), with a
range from < LOD of 0.4 µg/L to 42.6 µg/L.
However, because the number of urine samples
collected from subjects varied widely, subjects
contributed differentially to the median and
percentiles of the urinary BPA concentrations.
For instance, a subject with four urine samples
contributed four times as many data points as a
subject with one sample. In addition, multiple
urine samples from a given subjects are not
independent. To account for both of these
factors, we calculated the percentiles of the
urinary BPA distribution based on the geo-
metric mean of the urinary BPA concentra-
tions for each subject with two or more urine
samples and the single urine sample concen-
tration for subjects with one sample (Table 2).
After accounting for these factors, the median
was 1.30 µg/L (25th percentile, 0.72; 75th
percentile, 2.09). The median was slightly
lower among women (1.08 µg/L) than among
men (1.40 µg/L). Urinary concentrations
unadjusted for SG (Table 2) allow for
comparisons with other study populations,
because few studies have used SG to adjust for
urinary dilution.
Because spot urine samples were collected
at different times throughout the day, we
explored whether time of day was associated
with urinary SG-adjusted BPA concentrations
(Table 3). Urine samples collected before
0900 hours (time of collection ranged from
0530 to 0859 hours) had a median of 2.4 µg/L
compared with medians of 1.92 µg/L for sam-
ples collected from 0900 to 1159 hours,
whereas samples collected between noon and
1559 hours had a higher median of 3.24 µg/L.
Median BPA then decreased to 1.62 µg/L
among samples collected after 1600 hours
(range 1600 to 1830 hours). In mixed regres-
sion analysis, there was a statistically signiﬁcant
difference in geometric mean SG-adjusted
BPA concentration by time of day when urine
samples were collected (p = 0.01 for compari-
son of samples collected between noon and
1559 hours with those collected after
1600 hours).
Although age, BMI, sex, and pregnancy
status were not statistically signiﬁcant predic-
tors of urinary BPA concentrations, we found
weak associations after reverse transformation
Predictors of urinary bisphenol A concentrations
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Table 1. Subject demographics.
Characteristic All subjects (n = 82) Males (n = 37) Females (n = 45)
Age [years (mean ± SD)] 35.5 ± 4.4 35.7 ± 5.3 35.2 ± 3.6
BMI (mean ± SD) 26.8 ± 5.8 28.2 ± 5.2 25.7 ± 6.1
Race [n (%)]
Caucasian 70 (85) 30 (81) 40 (89)
African-American 0 (0) — —
Asian 7 (9) 4 (11) 3 (7)
Other 5 (6) 3 (8) 2 (4)
Smoking history [n (%)]
Never 56 (68) 27 (73) 29 (64)
Former 21 (26) 7 (19) 14 (31)
Current 5 (6) 3 (8) 2 (4)
Table 2. Distribution of urinary BPA concentrations (µg/L).
Percentiles
No. GM 10th 25th 50th 75th 90th 95th Max
Initial urine sample only
All subjects 82 1.31 0.18 0.60 1.30 2.70 5.00 5.80 42.6
Male 37 1.62 0.60 1.00 1.40 3.10 5.10 6.50 18.7
Female 45 1.09 0.18 0.50 0.90 2.20 4.80 5.80 42.6
All urine samplesa
All subjects 82 0.33 0.72 1.30 2.09 4.16 4.80 12.8
Male 37 0.50 0.92 1.40 3.08 4.50 5.00 6.5
Female 45 0.25 0.50 1.08 1.80 4.16 4.80 12.8
Abbreviations: GM, geometric mean; Max, maximum. Levels < LOD were recorded as 0.18 (1/2 LOD). Urinary concentra-
tions were not adjusted for SG to allow for comparison with other studies in the literature.
aThe percentile distributions were based on the GM of the urinary BPA concentrations for each subject with two or more
urine samples (48 subjects) and the single urine sample concentration for subjects with one sample (34 subjects).
Table 3. Median (25th and 75th percentiles) and geometric mean SG-adjusted BPA concentrations (µg/L)
grouped by time of urine sample collection.
Time No. Median (25th and 75th percentile) Geometric mean
0530–0859 hours 49 2.40 (1.20, 4.32) 2.37
0900–1159 hours  106 1.92 (1.07, 3.49) 2.01
1200–1559 hours 52 3.24 (1.96, 5.32) 3.42
1600–1830 hours 10 1.62 (0.80, 2.40) 1.42of the regression coefﬁcients. Controlling for
SG, BPA concentrations increased by 2%
[95% conﬁdence interval (CI), –2 to 6%) for
each year age increased. To explore associations
of BMI with urinary BPA concentrations, BMI
was categorized as underweight (< 20), normal
(20–24.9), overweight (25–29.9), or obese
(≥ 30). Compared with normal BMI, under-
weight BMI was associated with a 49%
increase (95% CI, –25 to 197%) in BPA con-
centration, overweight BMI with an 8%
increase (95% CI, –27 to 61%), and obese
BMI with a 3% decrease (95% CI, –38 to
51%). BPA concentrations for women were
9% lower (95% CI, –35 to 28%) than those
for men, and concentrations for urine samples
collected from women while pregnant were
26% higher (95% CI, –26 to 115%) than
urine samples collected from nonpregnant
women. Restricting to the 10 women who
became pregnant during follow-up, samples
collected while women were pregnant had con-
centrations 33% higher (95% CI, –33 to
165%) than those collected prepregnancy (n =
49 samples).
To investigate within-couple correlation of
urinary BPA concentrations, we first noted
that the covariance parameters in the mixed-
effects models were estimated to be approxi-
mately 0.04 for subject, 0.04 for within-couple
collection date, and 0.11 for residual variance.
Because the variance component for couples
had been estimated to be zero, these numbers
suggest that BPA concentrations between part-
ners will correlate substantially only when the
measurements are taken on the same day. As a
second approach, we used the geometric mean
of SG-adjusted BPA concentrations as an aver-
age exposure measurement for each individual;
using ordinary linear regression, we compared
the female’s geometric mean with that of her
male partner (n = 24 couples). We observed no
significant association between the means
(Spearman correlation = 0.04, p = 0.84); simi-
lar results were found using arithmetic means
or arithmetic means on the log10 scale (p =
0.92 and 0.84).
However, when female BPA concentration
(SG-adjusted and log10-transformed) on a par-
ticular day was compared with that of her male
partner on the same day (n = 42 pairs of day-
matched, couple-matched specimens), a moder-
ately strong association was found (Figure 1).
Using a linear mixed model accounting for cor-
relation from repeated observations on the same
couple by inclusion of random effects, each one
unit increase in male log10 SG-adjusted BPA
urine concentration was estimated to cor-
respond to a 0.428 increase (95% CI, 0.110 to
0.747) in the female partner’s urine BPA
concentration from the same day (Spearman
correlation = 0.36; p = 0.02).
Among subjects with at least three urine
samples, the calendar time between collection
of the ﬁrst and last urine samples ranged from
14 to 482 days, with a mean (median) of 172
(150) days. The time between collection of
ﬁrst and last urine samples ranged from 150 to
482 days for subjects with at least six samples,
with a mean (median) of 304 (329) days.
Sensitivity and speciﬁcity analyses to assess
the ability of one urine sample to predict a
subject’s exposure tertile are shown in Table 4.
The proportion of subjects who “truly” were
in the highest exposure tertile (top 33%),
identiﬁed as those with a single urine sample
collected anytime during the subject’s partici-
pation in the study (i.e., sensitivity) was 0.64.
The proportion of subjects who “truly” were
in the lowest exposure tertiles (e.g., first and
second tertiles) and classified as such (i.e.,
speciﬁcity) was 0.76. The proportion of single
urine samples that classiﬁed an individual in
the highest tertile who was “truly” classiﬁed in
the highest group (i.e., positive predictive
value) was 0.63. We also calculated these
measures for the ability of two urine samples
to predict an individual’s geometric mean
(Table 4). When two BPA samples were used
to classify each subject, we found increases in
sensitivity (0.67), speciﬁcity (0.84), and posi-
tive predictive value (0.85).
Discussion
Apart from a small study in Japan on ﬁve sub-
jects (four men and one woman) (Arakawa
et al. 2004), we report some of the ﬁrst data on
long-term temporal variability of urinary BPA
concentrations among a large sample of both
men and women. We found temporal within-
subject variability in urinary SG-adjusted BPA
concentrations. As suggested by earlier small
studies, we also found that men had slightly
higher BPA concentrations than women.
Japanese researchers reported associations of
male sex and androgen levels with higher BPA
concentrations (Takeuchi and Tsutsumi 2002;
Takeuchi et al. 2004). However, Kim et al.
(2003) found that BPA urine concentrations in
males and females were similar. Further explo-
ration of a potential sex- or androgen-related
difference in urinary BPA concentrations is
needed to resolve the inconsistencies across
limited studies.
To the best of our knowledge, the present
study is the ﬁrst to compare urinary BPA con-
centrations in women before and during preg-
nancy. Although only 10 women contributed
data, there was a nonsigniﬁcant 33% increase
in urinary concentrations of BPA during
pregnancy compared with prepregnancy.
During pregnancy, there are numerous physi-
ologic changes that may affect BPA distri-
bution, metabolism, and/or clearance. For
Mahalingaiah et al.
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Table 4. Sensitivity, specificity, and positive predictive value of one or two urine samples to predict the
highest BPA tertile.a
Sensitivity Speciﬁcity Positive predictive value
One sampleb 0.64 0.76 0.63
Two samplesc 0.67 0.84 0.85
aBPA tertile cutoff values (µg/L): < 1.61; ≥ 1.61 to < 3.11; ≥ 3.11. bAnalysis included 149 samples from 31 subjects with at
least three repeat urinary BPA measures. cAnalysis included 67 samples from 8 subjects with at least six repeat urinary
BPA measures.
Figure 1. Within-couple variability shown by urinary SG-adjusted BPA concentrations among female (dia-
monds and solid lines) and male (squares and broken lines) partners with at least two urine samples col-
lected on the same day (n = 11 couples).
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Day of studyinstance, the glomerular filtration rate is
increased during pregnancy, creatinine clear-
ance increases, and in some pregnant women,
urine output increases due to increased metab-
olism of antidiuretic hormone. To explore
whether changes in urinary concentrations of
BPA are partially due to changes in urine SG
during pregnancy, we regressed SG on preg-
nancy status, clustering by subject. The esti-
mated SG for pregnant women was 0.0029
higher than for nonpregnant women (95%
CI, –0.0014 to 0.0071; p = 0.19). Therefore,
changes in SG during pregnancy would con-
tribute to a slightly lower SG-adjusted BPA
concentration, rather than an increase, as we
observed during pregnancy.
Other potential explanations for differ-
ences in urinary BPA concentrations during
pregnancy include a) changes in exposure,
such as an increased use of products or in the
consumption of foods that contain BPA;
b) changes in volume of distribution and/or
altered sequestration of BPA into different
body fluid compartments, such as amniotic
fluid; and c) changes in BPA metabolism
and/or excretion. Application of physiologi-
cally based pharmacokinetic approaches is
necessary to better understand changes in
BPA dynamics during pregnancy, but it is
beyond the scope of the present report.
Because exposure to BPA is thought to be
primarily via ingestion, we hypothesized that
urinary BPA concentrations will be more simi-
lar among individuals that are partners than
those who are not partners. We found evidence
of a moderately strong relationship between
urinary BPA concentrations in samples col-
lected on the same day among male and female
partners. This suggests that BPA exposure
occurs through a common household lifestyle
factor, most likely diet. This ﬁnding warrants
further investigation because sources of BPA
among the general population are unclear.
Interestingly, there appeared to be a trend
in urinary BPA concentrations by the time of
day when the sample was collected. Urinary
BPA concentrations were highest in the sam-
ples collected between 1200 and 1600 hours,
compared with morning or late afternoon/
evening samples. This may reflect dietary
BPA exposure during the midday meal,
because BPA has a short half-life (Volkel et al.
2002). We did not collect data on the time of
day meals or foods were consumed through-
out the day, so we are unable to conﬁrm this
directly.
We also conducted sensitivity and speci-
ﬁcity analyses to determine the ability of one
urine sample or a pair of urine samples to pre-
dict long-term urinary BPA concentrations
over several months. Despite the presence of
temporal variability in urinary BPA concentra-
tions, our sensitivity and specificity analyses
suggested that a single urine sample correctly
classiﬁed subjects into the highest BPA expo-
sure tertile based on the geometric mean of
repeat samples for that subject. However,
there were several limitations to our approach.
First, because there was no gold standard to
use as the “true” urinary BPA concentration,
we relied on using the geometric mean of
repeat urine sample concentrations. How well
these geometric means represent an individ-
ual’s true exposure is unclear. Furthermore,
there is structural dependency between the
“true” urinary BPA concentrations and the
single or pair of urine samples that will over-
inﬂate the sensitivity and speciﬁcity. Second,
the timing of the collection of the repeat urine
samples was not balanced. For instance, the
duration between the collection of consecutive
repeat urine samples ranged from 3 days to a
year or more, but all samples were treated
equally without respect to the time between
collection. Thus, although we found that two
urine samples improved the ability to predict
BPA exposure tertiles, the preferred temporal
spacing of the two samples is currently unclear.
However, based on previous work on other
nonpersistent chemicals, such as phthalates, at
least 1 month between samples is preferable
when the exposure duration of interest is over
several months (Hauser et al. 2004).
Despite a much longer span of time
between the collection of the first and last
urine samples among subjects in the two-
sample sensitivity analysis, the predictive abil-
ity was increased with the collection of a
second sample. For the subset included in the
two-sample sensitivity analysis (subjects with
at least six samples), the average time interval
between samples was 304 days compared with
175 days among the group of subjects
included in the one-sample sensitivity analysis
(subjects with at least three samples). Because
samples from the two-sample sensitivity
analysis represent a much wider exposure
period, we would not have been surprised by
a lack of improvement in the two-sample
analysis compared to the one-sample analysis.
However, our ﬁnding of increased predictive
ability in the two-sample analysis may suggest
that, because BPA exposure is ubiquitous and
likely occurs daily, urinary concentrations
exist in a relatively pseudosteady state over the
course of months or years (National Research
Council 2006).
The urinary BPA concentrations found in
the present study were within the range
reported from studies in several countries,
including Japan, Korea, and the United States.
In a nonrepresentative subset of NHANES III
that included men and women between 20
and 59 years of age, the geometric mean uri-
nary BPA concentration was 1.33 µg/L
(Calafat et al. 2005). Among girls 6–8 years of
age, Wolff et al. (2007) reported a geometric
mean of 2.0 µg/L. Yang et al. (2003) reported
a geometric mean urinary BPA concentration
of 9.54 µg/L among 73 Koreans (34 men and
39 women) In another Korean study on
15 men and 15 women, Kim et al. (2003)
reported a mean (SE) urinary BPA concentra-
tion of 2.82 µg/L (0.73) and 2.76 µg/L (0.54),
respectively, with no difference by sex. Among
48 women in Japan, Ouchi and Watanabe
(2002) reported a median urinary BPA con-
centration of 1.2 µg/L, with a range of
0.2–19.1 µg/L. Comparisons across studies are
difﬁcult because they may be confounded by
differences in timing and methods of urine
collection, containers used, analytical methods
to quantify BPA, different limits of detection,
and methods for correction of urinary dilu-
tion. Additionally, country-speciﬁc regulations
on the use of BPA and occupational exposure
to BPA may affect urinary concentrations.
Countries with bans on the use of BPA prod-
ucts for packaging foods may have populations
with lower urinary and serum BPA concentra-
tions. However, we are not aware of data
showing population differences in exposure
before and after bans.
Conclusion
Despite within-person variability in urinary
BPA concentrations, a single sample is predic-
tive of long-term exposure (over weeks to
months) and provides good sensitivity to clas-
sify individuals into tertiles in epidemiologic
studies. The addition of a second urine sample
improved this classiﬁcation ability. Although
we did not ﬁnd strong relationships of urinary
BPA concentrations with age, sex, BMI, and
pregnancy status, these associations were sug-
gestive and are worthy of further follow-up.
Discovery of whether urinary concentrations
increase during pregnancy, reflecting either
increased exposure or alterations in metabo-
lism during pregnancy, is especially important.
The correlation between urinary BPA concen-
trations among male and female partners sug-
gests that BPA exposure is shared through diet
or common residential source(s). Finally,
replication of this study in other populations,
including the general population, should be
conducted to determine whether predictors
vary across populations. In addition, further
work needs to be done to determine the utility
of urine samples to define an individual’s
exposure level during pregnancy.
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